Salivary and serum nitric oxide synthase, macrophage inflammatory protein 1 alpha and macrophage migration inhibitory factor levels in periodontal disease

被引:0
|
作者
Oner, Fatma [1 ]
Onat, Faruk Cagri [2 ]
Karasu, Yerda Ozkan [2 ,3 ]
机构
[1] Bahcesehir Univ, Fac Dent Med, Dept Periodontol, Istanbul, Turkiye
[2] Ataturk Univ, Fac Dent & Med, Dept Periodontol, Erzurum, Turkiye
[3] Ataturk Univ, Fac Dent Med, Dept Periodontol, TR-25200 Yakutiye Erzurum, Turkiye
关键词
Gingivitis; iNOS; MIP-1; alpha; MIF; Periodontitis; PERI-IMPLANT DISEASES; 2017 WORLD WORKSHOP; CONSENSUS REPORT; MIP-1-ALPHA; EXPRESSION; BIOMARKERS; MIF; CLASSIFICATION; CONTRIBUTES; IMMUNITY;
D O I
10.1016/j.heliyon.2024.e25888
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Periodontal disease is multifactorial inflammatory disease involving both gingivitis and periodontitis. Inducible nitric oxide synthase (iNOS), macrophage inflammatory protein 1 alpha (MIP-1 alpha) and macrophage migration inhibitory factor (MIF) are mediators contributing to the progression of periodontal diseases with distinct functions. The aim of this study is to evaluate the local and systemic iNOS, MIP-1 alpha and MIF concentrations in patients having periodontal disease with different severities. Design: The study was conducted on 88 individuals equally divided into four groups; 1) Periodontally Healthy 2) Gingivitis 3) Stage I-II Periodontitis 4) Stage III-IV Periodontitis. Saliva and serum samples were obtained from each individual and then periodontal examinations were performed. Plaque and bleeding on probing indexes, probing depths and clinical attachment levels were measured on each tooth to determine the periodontal status. Concentrations of iNOS, MIP-1 alpha and MIF were measured with enzyme -linked immunosorbent assay. Results: Patients with stage I-II and stage III-IV periodontitis had more iNOS levels than periodontally healthy people in serum and saliva (p <= 0,001 for serum; p < 0,05 for saliva). Stage III-IV periodontitis group had significantly more serum-iNOS levels than that in gingivitis group (p = 0,005). When compared with periodontally healthy individuals, MIP-1 alpha levels in stage III-IV periodontitis patients were measured significantly more in saliva; (p = 0,016) but less in serum (p = 0,006) samples. More serum-MIF concentrations were observed in stage I-II periodontitis groups than that in periodontally healthy individuals (p < 0,05). Conclusion: Increased salivary and serum iNOS and serum-MIF levels in different stages of periodontitis suggest that these molecules might be involved in periodontal disease pathogenesis. Also, oral microenvironment may stimulate the enhanced MIP-1 alpha concentration in advanced periodontitis cases.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis
    Shimizu, T
    Nishihira, J
    Mizue, Y
    Nakamura, H
    Abe, R
    Watanabe, H
    Ohkawara, A
    Shimizu, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (06) : 989 - 990
  • [32] Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis
    Kanemitsu, Hirohito
    Matsunawa, Mizuho
    Wakabayashi, Kuninobu
    Sato, Michihito
    Takahashi, Ryo
    Odai, Tsuyoshi
    Isozaki, Takeo
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2009, 1 : 1 - 8
  • [33] Serum levels of macrophage migration inhibitory factor and interleukin 17 in patients with nonsegmental vitiligo
    Sorour, Osama
    Nassar, Eman
    Eldin Ahmed, Somaya
    Farid, Carmen
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2020, 17 (01): : 13 - 18
  • [34] Macrophage Migration inhibitory Factor in Clinical Kidney Disease
    Bruchfeld, Annette
    Wendt, Marten
    Miller, Edmund J.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [35] Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?
    Hertelendy, Johannes
    Reumuth, Georg
    Simons, David
    Stoppe, Christian
    Kim, Bong-Sung
    Stromps, Jan-Philipp
    Fuchs, Paul C.
    Bernhagen, Juergen
    Pallua, Norbert
    Grieb, Gerrit
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (05) : 601 - 605
  • [36] Serum macrophage migration inhibitory factor in the prediction of preterm delivery
    Pearce, Brad D.
    Garvin, Sicily E.
    Grove, Jakob
    Bonney, Elizabeth A.
    Dudley, Donald J.
    Schendel, Diana E.
    Thorsen, Poul
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (01) : 46.e1 - 46.e6
  • [37] Elevated Serum Levels of Macrophage Migration Inhibitory Factor Are Associated with Progressive Chronic Cardiomyopathy in Patients with Chagas Disease
    Cutrullis, Romina A.
    Petray, Patricia B.
    Schapachnik, Edgardo
    Sanchez, Ruben
    Postan, Miriam
    Gonzalez, Mariela N.
    Martin, Valentina
    Corral, Ricardo S.
    PLOS ONE, 2013, 8 (02):
  • [38] Serum macrophage migration inhibitory factor is correlated with atrial fibrillation
    Wan, Chunfu
    Li, Zhihua
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (02)
  • [39] INHIBITION OF NITRIC OXIDE SYNTHASE ENHANCES THE PRODUCTION OF TUMOR NECROSIS FACTOR - ALPHA IN MACROPHAGE CELLS
    Islam, Mohammed T.
    Agarwal, Deepmala
    Francis, Joseph
    Matrougui, Khalid
    Majid, Dewan S. A.
    FASEB JOURNAL, 2011, 25
  • [40] Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia
    Todros, T
    Bontempo, S
    Piccoli, E
    Ietta, F
    Romagnoli, R
    Biolcati, M
    Castellucci, M
    Paulesu, L
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 123 (02) : 162 - 166